Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$305M |
| 2 |
Tesla
TSLA
|
+$304M |
| 3 |
ExxonMobil
XOM
|
+$277M |
| 4 |
Warner Bros
WBD
|
+$263M |
| 5 |
Linde
LIN
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$403M |
| 2 |
CERN
Cerner Corp
CERN
|
+$371M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$310M |
| 4 |
Philip Morris
PM
|
+$254M |
| 5 |
S&P Global
SPGI
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.19% |
| 2 | Healthcare | 14.61% |
| 3 | Financials | 12.06% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Myriad Genetics
MYGN
$290M
| $15M | ﹤0.01% |
824,414
-101,548
| -11% | -$2.11M |
|
1702
Emergent Biosolutions
EBS
$235M
| $15M | ﹤0.01% |
481,774
-107,505
| -18% | -$3.67M |
|
1703
C3.ai
AI
$1.54B
| $14.9M | ﹤0.01% |
818,258
+75,521
| +10% | +$1.39M |
|
|
GCP
1704
DELISTED
GCP Applied Technologies Inc.
GCP
| $14.9M | ﹤0.01% |
476,886
-62,740
| -12% | -$1.96M |
|
1705
Rivian
RIVN
$22.2B
| $14.9M | ﹤0.01% |
577,839
+111,441
| +24% | +$3.48M |
|
1706
ePlus
PLUS
$2.31B
| $14.9M | ﹤0.01% |
279,578
-17,714
| -6% | -$991K |
|
1707
Kosmos Energy
KOS
$1.51B
| $14.8M | ﹤0.01% |
2,396,867
+551,074
| +30% | +$3.98M |
|
1708
Deluxe
DLX
$1.1B
| $14.8M | ﹤0.01% |
683,182
-16,624
| -2% | -$423K |
|
1709
Supernus Pharmaceuticals
SUPN
$2.81B
| $14.8M | ﹤0.01% |
511,504
-33,867
| -6% | -$970K |
|
1710
Guardant Health
GH
$21.1B
| $14.8M | ﹤0.01% |
366,316
+17,385
| +5% | +$861K |
|
1711
iShares S&P 500 Growth ETF
IVW
$77.6B
| $14.8M | ﹤0.01% |
244,422
-598
| -0.2% | -$39.6K |
|
|
DEN
1712
DELISTED
Denbury Inc.
DEN
| $14.7M | ﹤0.01% |
245,482
-785
| -0.3% | -$55.8K |
|
1713
PRA Group
PRAA
$776M
| $14.7M | ﹤0.01% |
404,876
-53,666
| -12% | -$2.13M |
|
1714
Virtus Investment Partners
VRTS
$1.13B
| $14.7M | ﹤0.01% |
85,971
-293
| -0.3% | -$55.3K |
|
1715
Mativ Holdings
MATV
$674M
| $14.7M | ﹤0.01% |
585,163
-10,652
| -2% | -$282K |
|
1716
Ligand Pharmaceuticals
LGND
$5.87B
| $14.7M | ﹤0.01% |
263,953
-31,108
| -11% | -$1.77M |
|
1717
Hilton Grand Vacations
HGV
$3.57B
| $14.7M | ﹤0.01% |
410,985
-23,321
| -5% | -$1.04M |
|
1718
Xencor
XNCR
$1.74B
| $14.7M | ﹤0.01% |
535,787
-40,989
| -7% | -$1.01M |
|
1719
Open Text
OTEX
$5.94B
| $14.6M | ﹤0.01% |
386,591
+12,167
| +3% | +$482K |
|
|
NVRO
1720
DELISTED
NEVRO CORP.
NVRO
| $14.6M | ﹤0.01% |
333,337
-13,479
| -4% | -$741K |
|
|
AQUA
1721
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $14.6M | ﹤0.01% |
448,769
-40,036
| -8% | -$1.52M |
|
|
BAND
1722
Bandwidth Inc
BAND
$1.74B
| $14.6M | ﹤0.01% |
773,750
-35,864
| -4% | -$829K |
|
1723
Encore Capital Group
ECPG
$2.2B
| $14.6M | ﹤0.01% |
251,899
-23,751
| -9% | -$1.41M |
|
|
VRTV
1724
DELISTED
VERITIV CORPORATION
VRTV
| $14.5M | ﹤0.01% |
134,009
-11,936
| -8% | -$1.62M |
|
1725
Telkom Indonesia
TLK
$14.6B
| $14.5M | ﹤0.01% |
535,225
-10,408
| -2% | -$311K |
|
Similar funds
Bank of New York Mellon's Q2 2022 Portfolio in Review
As of Q2 2022, Bank of New York Mellon held 4,820 positions worth $438B, down 15% from $516B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Bank of New York Mellon's Q2 2022 filing shows 167 new, 1,786 increased, 2,376 reduced and 241 closed positions. Its largest new stake was Hess Midstream: 1,736,004 shares worth $48.6M. The largest sale was Apple, an estimated $403M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2022 buy was Hess Midstream: 1,736,004 shares worth $48.6M.
- Bank of New York Mellon added most to Goldman Sachs in Q2 2022, an estimated $305M increase.
- Bank of New York Mellon's biggest Q2 2022 reduction was Apple, cutting an estimated $403M.
- Bank of New York Mellon fully exited Cerner Corp in Q2 2022, selling an estimated $371M.
- Bank of New York Mellon's ten largest holdings make up 19% of its $438B portfolio in Q2 2022.
- Bank of New York Mellon opened 167 new positions and closed 241 in Q2 2022.
- Bank of New York Mellon's portfolio value fell 15% quarter-over-quarter to $438B.
Based on Bank of New York Mellon's 13F filing for Q2 2022, filed 15 Aug 2022.